Use of Insulin Sensitizers in NASH

Mouen Khashab, Naga Chalasani

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

Original languageEnglish (US)
Pages (from-to)1067-1087
Number of pages21
JournalEndocrinology and Metabolism Clinics of North America
Volume36
Issue number4
DOIs
StatePublished - Dec 1 2007

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Use of Insulin Sensitizers in NASH'. Together they form a unique fingerprint.

  • Cite this